Placental Abruption
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
Study on Retroplacental Hematomas in Finistère
Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity